跳至主要内容
临床试验/NCT01094015
NCT01094015已完成4 期

Lidocaine-Prilocaine (EMLA) Cream as Analgesia in Hysteroscopy Practice: a Prospective Randomized Clinical Trial

Consorci Sanitari de Terrassa1 个研究点 分布在 1 个国家目标入组 92 人开始时间: 2007年7月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
92
试验地点
1
主要终点
pain reduction in the performance of hysteroscopy

研究概览

简要总结

The purpose of this study is to demonstrate that Lidocaine-Prilocaine cream decrease pain during hysteroscopy diagnostic practice.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • patients that he must perform a diagnostic hysteroscopy
  • acceptance to participate in the study signed informed consent
  • Exclusion Criteria prerandomization:
  • hypersensitivity or allergy to anesthetics
  • refusal of the patient
  • patients under age 18 and pregnant
  • Exclusion Criteria postrandomization:
  • unbearable pain that involves other analgesic measures
  • allergic reactions to topical anesthetics

排除标准

  • 未提供

研究组 & 干预措施

Lidocaine-Prilocaine cream

Active Comparator

干预措施: lidocaine-prilocaine cream (Drug)

placebo

Placebo Comparator

干预措施: gel application for the transmission of ultrasound (Other)

结局指标

主要结局

pain reduction in the performance of hysteroscopy

时间窗: after hysteroscopy and a month later

decrease in pain immediately after the completion of hysteroscopy and one month after completion of the diagnostic test by an analogue pain scale

次要结局

  • sense of discomfort experience during the procedure(a month after hysteroscopy)

研究者

发起方
Consorci Sanitari de Terrassa
申办方类型
Other

研究点 (1)

Loading locations...

相似试验